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Abstract
Stroke, the loss of neurons after ischemic insult to the brain, is one of the leading causes of death and disability worldwide.
Despite its prevalence and severity, current therapy is extremely limited, highlighting the importance of further
understanding the molecular events underlying ischemia-induced neuronal cell death. An ischemic area can be subdivided
into two separate pathophysiological regions: the rapidly dying necrotic core, and the potentially salvageable apoptotic
penumbra. Understanding molecular events occurring in the apoptotic ischemic penumbra may give greater insight into
mechanisms controlling this salvageable tissue. miRNAs are known to have key roles in the regulation of gene expression in
numerous pathological conditions, including the modulation of distinct pathways in stroke. However, previous studies have
profiled miRNAs in the whole ischemic infarct, and do not differentiate between miRNA regulation in the necrotic core
versus the apoptotic penumbra. We asked if there were unique miRNAs that are differentially regulated following ischemic
insults in the salvageable apoptotic penumbra. miRNA expression profiles were compared in the whole infarct from in vivo
stroke models, using the three vessel occlusion approach, to an in vitro model of the ischemic penumbra, prior to apoptotic
induction. Multiple miRNAs were found to be differentially regulated following ischemic insults in each system. However,
miR-19b, miR-29b-2* and miR-339-5p were significantly up-regulated in both model systems. Further, we confirmed these
results in a neuroblastoma cell line subjected to a penumbra-like ischemic insult that induced the apoptotic cell death
pathway. The data show that miR-19b, miR-29b-2* and miR-339-5p are up-regulated following ischemic insults and may be
regulating gene expression to control important cellular pathways in the salvageable ischemic penumbra. Further
investigation of their role and mRNA target identification may lead to new insights into the molecular mechanisms taking
place in the salvageable apoptotic penumbra.
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Introduction
Stroke is the third most common cause of death in the Western
world and has a greater disability impact compared to other
diseases [1]. The majority of strokes are ischemic, caused by a
restriction of blood flow to a specific area of the brain [2]. Many
drugs have been developed for the treatment of strokes, but have
failed during clinical trials [3]; and thus current therapy is limited
to the thrombolytic drug rt-PA (recombinant tissue-plasminogen
activator). Often patients are not suitable candidates to receive this
drug, since its use is restricted to the first 4.5 h after stroke [4–7].
This underscores the importance of further investigation into the
molecular mechanisms underlying ischemia induced neuronal cell
death for the development of novel therapeutics.
Ischemic stroke causes neuronal cell death that can be separated
into two distinct regions, the core and penumbra [8–13]. The
ischemic core experiences the greatest reduction in blood flow,
receiving approximately 20% of its usual supply [8,9,12,14].
Neurons within this region die within minutes to hours, mainly via
necrotic mechanisms [10,11,13]. The area surrounding the core,
the ischemic penumbra, is functionally silent but metabolically
active and can account for up to half of the ischemic infarct at
early stages [15,16]. The penumbral neurons are able to repolarise
following an ischemic event, however, this is carried out at the
expense of energy consumption. Since the deficiency of oxygen
and glucose delivery impairs the cells’ ability to maintain ionic
gradients, the neurons may depolarise. These events can cycle
multiple times until the neurons are depleted of energy.
Substantial evidence shows that cells in the penumbra will die
over a period of hours to weeks mainly via an apoptotic pathway
[8,11,12,17–29].
Studies have identified alterations in post-translational modifi-
cations of BCL-2 family proteins following ischemic injury [30–
35], indicating a role for the intrinsic pathway of apoptosis in the
ischemic penumbra. Recent advances in developing better stroke
therapies are now focussing on neuroprotective strategies that are
targeted to the salvageable penumbra. This delayed apoptotic cell
death has become the focus of many studies as it provides a larger
window for effective therapy in comparison to the rapidly dying
necrotic core.
MicroRNAs (miRNAs) have been identified to play an
important role in the progression of neuronal death following
cerebral ischemia [36–40]. MiRNAs are short non-coding RNA
molecules that negatively regulate gene expression by base pairing
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with the 39UTR of target mRNAs to inhibit both translation and
decrease mRNA stability [41–49]. However, miRNA profiling
data from ischemic models has often been generated at late time
points, when cell death has occurred, and tissue samples used have
included the rapidly dying necrotic core [36–40]. In order to
understand the involvement of miRNAs in the apoptotic processes
following stroke, this study focused on investigating the early post-
transcriptional regulation of gene expression specifically in the
ischemic penumbra.
The current study investigated changes in miRNA expression in
rat cortical neurons exposed to an in vitro model of the ischemic
penumbra (Oxygen Glucose Deprivation; OGD) before cell death
was detected. In addition to this, miRNA microarrays were
conducted on an in vivo model of transient cerebral ischemia at a
time point where the salvageable apoptotic cell death of the
penumbra is occurring. Our data suggest that miR-19b, miR-29b-
2* and miR-339-5p are all up-regulated in response to ischemia,
both in vivo and in vitro. These miRNAs were up-regulated before
the detection of neuronal cell death (in vitro) and following
establishment of the infarct (in vivo). Further, we also found that
these miRNAs were up-regulated in neuroblastoma cells (N2As)
following ischemic insults. This study highlights that miR-19b, -
29b-2* and -339-5p are modulated in response to ischemic insults
and may have a role in ischemia induced cell death.
Materials and Methods
Ethics Statement
All procedures were conducted in accordance with the UK
Animals (Scientific Procedures) Act, 1986 (Home Office project
licence 80/2323). The University of Leicester animal welfare
committee approved all animal protocols. All surgery was
performed under anaesthesia, efforts were taken to ameliorate
suffering and mice were allowed free access to food and drink
before and after surgery. Animals were humanely culled, by
schedule 1 cervical dislocation, if they exceeded severity limits post
surgery or at the end of the study. Wistar rats were fed and housed
under standard conditions. Both adult and embryos were
humanely culled using schedule 1 cervical dislocation.
Primary cell culture
Cortical neurons were prepared from E17-18 embryos from
Wistar rats. The cortex was extracted and the hippocampus was
discarded, the tissue mechanically dissociated followed by enzy-
matic dissociation with 5% Trypsin + 0.05 mg/ml Dnase I at
37uC for 10 min. The tissue was centrifuged for 3 min at 1500 rpm
and resuspended in Neurobasal medium supplemented with 10%
heat inactivated FCS, 1x Glutamax, 50 Units/ml Penicillin and
50 mg/ml Streptomycin (Sigma). The neurons were seeded on to
Poly-L-Lysine coated plates at a density of 86105 cells/ml. After
60 min, the plating medium was replaced with maintenance
medium: Neurobasal medium supplement with 2% B27, 1x
Glutamax, 50 Units/ml Penicillin and 50 mg/ml Streptomycin
(Sigma). On 7 days in vitro (DIV), medium was supplemented with
fresh maintenance medium and 10 mM cytosine arabinoside
(Sigma) was added to prevent glial cell contamination.
N2A cell culture
Mouse Neuroblastoma cell lines (N2As) were a kind gift from
Miguel Martins (MRC Toxicology Unit, Leicester; originally
purchased from ATCC [CCL-131]). They were maintained in
DMEM + 10% FCS (Gibco). For OGD experiments, cells were
seeded at 56104 cells/mL at least 48 h prior to OGD induction.
Oxygen Glucose Deprivation
Cells were pre-treated with 10 mM DL-2-Amino-5-phosphono-
valeric acid (APV) (Sigma) and 10 mM (+)MK-801 (Sigma) for 20
min. Neurons were subjected to OGD by replacing medium with
glucose-free EBSS (116 mM NaCl, 5.37 mM KCl, 0.8 mM
MgSO4, 1.17 mM NaH2PO4, 1.8 mM CaCl2, 26.19 mM
NaHCO3) with the addition of 10 mM APV and 10 mM (+)MK-
801. EBSS was gassed with 95% N2/5% CO2 for 30 minutes, in a
water bath at 37uC. Neurobasal medium was removed from the
neurons, replaced with deoxygenated glucose free EBSS and
transferred to a pre-heated modular incubator chamber (Billups-
Rothenberg, USA). The chamber was flushed with 95% N2/5%
CO2 gas, sealed and placed into a 37uC incubator for 4 h.
Anaerobic indicator sticks (BD) were used to confirm an anoxic
environment within the chamber. Controls consisted of sister
cultures in which medium was changed to EBSS + 10 mM
Glucose, 10 mM APV and 10 mM (+)MK-801 and were placed in
a normoxic incubator at 37uC. OGD was terminated by removing
the EBSS and replacing it with fresh maintenance medium
supplemented with 10 mM APV and 10 mM (+)MK-801. OGD
experiments conducted with zVAD.fmk (MP Biomedicals) had a
20 min pre-treatment with the inhibitor, which was present in the
OGD media and reperfusion media.
3 Vessel Occlusion (3VO) Stroke Surgery
The 3 vessel occlusion stroke model technique [50] was
performed on C57BL/6J wild type mice (Charles River) at 8 to
14 weeks. Buprenorphine (Vetergesic) diluted in saline (0.1 mg/kg)
was pre-operatively administered to the animals as an analgesic as
well as for hydrating operated mice. Initial anaesthesia was
induced with a mixture of 3 L/min isofluorane followed by
maintenance anaesthesia at 1 to 2 L/min. O2 and N2O levels were
kept constant at 1 L/min and 0.8 L/min respectively. Body
temperature was maintained at around 36uC using a heating
blanket. A ventral midline incision of the neck was made and the
two common carotid arteries (CCA) were exposed followed by
clamping of the left CCA using an aneurism clip. The left
zygomatic arch was then removed to enable access to the skull and
the middle cerebral artery. A 1 mm thick burr hole was opened 1
mm superior–rostral to the foramen ovale to allow access to the
MCA followed by its permanent cauterisation using a bipolar
coagulator (Aura, Kirwan Surgical Products). After the MCA
occlusion, complete ischemia was induced for 30 minutes by
clipping the right CCA. After the termination of ischemia both
clips were removed allowing reperfusion for 24 h. Transient
cerebral ischemia using this model results in unilateral cortical
lesions affecting the left cortex. Sham operations performed
included the whole procedure but without the dual common
carotid artery occlusion and MCA cauterisation.
Cell Death Assays
Cells were treated with 0.5 mM Sytox Orange nuclear stain
(Invitrogen) (cell non-permeant, red fluorescence) and 5 mg/ml
Hoechst 33342 (Invitrogen) (cell permeant, blue fluorescence) for
30 min at 37uC. The neurons were then washed once and placed
in KREB/HEPES (KHB) buffer (130 mM NaCl, 5.4 mM KCl, 1
mM MgCl2, 1.8 mM CaCl2, 20 mM HEPES, 10 mM Glucose;
pH 7.4). Imaging was conducted by epifluorescence microscopy.
For time-lapse imaging analysis, cells were treated with 1 mM
Calcein AM (Molecular Probes) for 20 min, followed by a
complete media change 12 h later. Cells were placed onto a
heated stage microscope with CO2 control in a dark custom-built
enclosure (Solvent Scientific) for 30 min before imaging was
conducted. Staining was visualised using an Axiovert 200 M
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fluorescent microscope (Zeiss) and images were captured using a
Hamamatsu Orca-ER camera using MetaMorph (Molecular
Devices) software. Images were analysed to quantify the percent-
age of non-viable cells using Volocity 4.0 (Improvision).
Western blotting
Protein analysis was conducted by Western blot as previously
described [51]. Primary antibodies used: Cleaved Caspase 3,
1:1000, Cell Signalling Technology (cat. 9664); Gapdh, 1:10000,
Santa Cruz (cat. Sc-365062); Cytochrome C, 1:1000, BD
Pharmingen (cat. 556432); PARP, 1:1000, Cell Signalling Tech-
nology (cat. 9542); Erk (1/2), 1:1000, Cell Signalling Technology
(cat. 4695). Secondary antibodies used: Goat anti-mouse IgG
(H+L) horse radish peroxidase conjugate and Goat anti-rabbit IgG
(H+L) horse radish peroxidise conjugate, 1:25,000 (Bio-Rad) for
1 h at RT, followed by final washes in TBST (4610 min).
Immuno-reactive proteins were detected by Enhanced Chemilu-
minescence Plus Western Blotting Detection System (Amersham).
Immuno-reactivity was analysed using Image J software (NIH,
http://rsbweb.nih.gov/ij/index.html).
To assess cytochrome C release from mitochondria into the
cytoplasm, cells were collected using 0.05% Trypsin/0.5 nM
EDTA, centrifuged at 2006g for 3 min, and then lysed for 5 min
on ice (Lysis Buffer: 250 mM sucrose; 20 mM HEPES, 5 mM
MgCl2; 10 mM KCl; 1 mM EDTA, 1 mM EGTA, 0.03%
Digitonin and Protease inhibitor cocktail). The lysates were
centrifuged at 13000 rpm at 4uC for 3 min and the supernatant
(cytosolic fraction) was collected. A total of 5 mg of protein was
loaded onto a 10% polyacrylamide gel, transferred onto nitrocel-
lulose membrane and incubated with appropriate antibodies.
MicroRNA microarrays
Total RNA was extracted using the miRNeasy mini Kit
(Qiagen). The RNA 6000 Nano kit (Agilent) was used to assess
RNA quality and integrity on an Agilent Bioanalyzer 2100. All
samples were accepted on the basis that RNA integrity for each
sample was .8.0.
Microarray slides were prepared in the laboratory of Dr. Tim
Gant (MRC Toxicology Unit, Leicester) using the microRNA
sequences from the miRBase v16.0 database (www.mirbase.org).
Array slides were printed with probes, supplied by Exiqon
(Denmark), complimentary to all mouse and rat microRNAs,
including related viruses and controls. FlashTag 3DNA array
detection kits (Genisphere, PA, USA) were used to label 1 mg of
total RNA from control and ischemic samples (3 per group for in
vivo and in vitro samples). Arrays were scanned using an Axon4200
scanner and data was compiled using GenePix Pro 6.0 (Molecular
Devices, CA, USA). The microarray datasets can be viewed at
Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo Accession
Number: GSE51586).
Taqman microRNA assays
Total RNA, including microRNAs, was isolated from primary
neuronal cell cultures using miRNeasy Mini Kits (Qiagen).
Reverse transcription was performed using the Taqman miRNA
Reverse transcription kit (Applied Biosystems). Equal amounts of
RNA (100 ng) were reverse transcribed, using 100 mM dNTPs,
50 U reverse transcriptase, 0.4 U RNase Inhibitor, and specific
miRNA reverse transcriptase primers, with the following protocol:
16uC for 30 min, 42uC for 30 min, followed by 85uC for 5 min.
PCR was then conducted on the reverse transcription (RT)
products using the Taqman miRNA assay kit (Applied Biosys-
tems). Each PCR contained 1.33 mL of the RT product, 10 mL of
Taqman 2x Universal PCR Master Mix, 1 mL 20x Taqman
microRNAs Assay Reagent in a total volume of 20 mL. The
relative expression levels of miRNAs were normalised to
endogenous U6 snRNA expression for each sample. Each RT
product underwent PCR in triplicate. Validations using this
method were conducted on the same RNA processed on the
microarrays, with additional in vitro samples.
Electron microscopy
Electron Microscopy was kindly performed by David Dinsdale
(MRC Toxicology Unit, Leicester). In brief, cells were fixed in 2%
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) at 4uC
overnight and postfixed with 1% osmium tetroxide/1% potassium
ferrocyanide for 1 h at room temperature. After fixation, cells were
stained en bloc with 5% aqueous uranyl acetate overnight at room
temperature, dehydrated, and embedded in Taab epoxy resin
(Taab Laboratories Equipment Ltd., Aldermaston, UK). Ultrathin
sections were stained with lead citrate and recorded using a
Megaview 3 digital camera and iTEM software (Olympus Soft
Imaging Solutions GmbH, Mu¨nster, Germany) in a Jeol 100-CXII
electron microscope (Jeol UK Ltd., Welwyn Garden City, UK).
Flow Cytometry
Cells were trypsinised and collected, including those floating in
media. Total pooled cells (approximately 105 in total) were
centrifuged for 5 min at 2000 rpm at RT. Cells were washed in
PBS and resuspended in 0.5 mL of annexin V binding buffer (10
HEPES, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, pH 7.4). For each treatment group cells were left unstained
or stained with Annexin V for 10 min and 0.2 mM Propidium
Iodide (PI) for 2 min at RT. Cell samples, 10,000 events per
sample, were analysed on a Becton Dickinson Canto II (BD
Biosciences, USA) fitted with a 488 nm blue and 633 nm red
lasers. Annexin-FITC emission was detected using a 530/30 nm
filter and PI emission with a 585/42 nm filter. Negative controls
and single Annexin V or PI stained cells were used to adjust
voltages and compensation.
Statistical analysis
Data is presented as a mean 6 SEM, unless otherwise stated.
Statistical significance was tested using an unpaired t-test
(Graphpad Prism, Grapdhpad Software, USA). Statistical signif-
icance was accepted at p,0.05. * denotes p,0.05, ** denotes
p,0.01 and *** denotes p,0.001.
Results
OGD induces a time-dependent increase in apoptotic
neuronal cell death
Our study aimed to focus on the apoptotic component of
ischemia-induced neuronal injury. Previous studies have reported
that OGD is able to induce both necrosis and apoptosis [52,53].
Necrotic cell death occurs due to the excessive release of
glutamate, which binds to NMDA-receptors leading to an
excitatory response. Therefore, to minimise the level of necrotic
cell death within these cultures, neurons were pre-treated with
NMDA-receptor antagonists APV and (+)MK-801 [54–56].
Before proceeding, we assessed the degree of cell death in our
primary cortical neurons in normal culture conditions to be
2462% - a level of basal death that is frequently observed in 10–
11 DIV primary neuronal cultures [57–60]. To establish the
appropriate duration of an OGD insult required to induce
neuronal cell death, cortical neurons were exposed to control
EBSS containing oxygen and glucose (EBSS+Oxygen+Glucose) or
EBSS depleted of oxygen and glucose (OGD) for 2, 4 or 6 h. To
MiRNAs in Models of the Ischemic Penumbra
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terminate the OGD, the cells were placed in their normal
maintenance medium for 24 h, at which point cell death analysis
was conducted using Sytox/Hoechst.
EBSS containing oxygen and glucose significantly increased cell
death levels following a 6 h exposure, when compared to normal
culture conditions (Figure 1A). The results indicated 2763%
(n = 3), 6268% (p = 0.02, n = 5) and 8563% (p,0.0001, n = 5)
death in cultures exposed to 2, 4, and 6 h of OGD, respectively
(Figure 1A). As we wished to investigate early events associated
with ischemic injury, the minimum duration of OGD required to
induce cell death was selected; hence subsequent experiments were
conducted with the use of a 4 h OGD insult. For all subsequent
experiments we have referred to the EBSS containing oxygen and
glucose cohort as Controls.
Previous results had shown that cell death became apparent 8 h
after termination of the OGD insult (data not shown). To
investigate the time for cell death to manifest itself following an
OGD insult, rat cortical neurons were imaged from 8 h to 24 h
post-OGD termination (Figure 1B). Cortical neurons were
incubated with 1 mM calcein AM for 20 min prior to OGD to
visualise the proportion of viable cells at hourly intervals. The data
demonstrated that neuronal cell death became significantly higher
than controls at 10 h post-OGD termination; where controls had
1962% and OGD-treated neurons had 4066% cell death
(p = 0.04, n = 3). OGD induced cell death levels rose at a steady
rate reaching 7562% at 24 h post-termination.
To determine the pathway of OGD- induced neuronal cell
death we next sought to assess whether death was dependent on
caspases. OGD was conducted with the addition of 100 mM
zVAD.fmk, a pan-caspase inhibitor (Figure 2A). We observed a
general decrease in levels of cell death following treatment with
zVAD.fmk. Cell death at 24 h post-OGD termination was
significantly reduced to 5465%, compared to naı¨ve OGD treated
cells (p = 0.04, n = 3). The results suggested that OGD-induced
neuronal cell death is partially established by the activation of
caspases.
Additionally, Western blot analysis conducted in order to
identify characteristic hallmarks of apoptotic cell death revealed an
increase in cytoplasmic Cytochrome C following OGD exposure
(Figure 2B and 2C). Similarly, we observed increased levels of
Figure 1. OGD-induced cell death in rat cortical neurons. A. OGD caused an increase in neuronal cell death levels, analysed by sytox/hoechst
imaging, which correlated with increased durations of OGD. Basal levels of cell death within our cultures, under normal culture conditions, were
determined as 23.762% (n = 3). Neurons were placed in EBSS with or without oxygen and glucose. Cells with EBSS plus oxygen and glucose
(EBSS+Oxygen+Glucose) only demonstrated a significant increase in levels of death, in comparison to controls, following 6 h of exposure. 2 h of OGD
did not increase cell death levels above those in EBSS+Oxygen+Glucose controls. However, 4 and 6 h of OGD increased cell death levels significantly
to 62.468.2% (p = 0.026, n = 5) and 84.963.2% (p,0.0001, n = 5) respectively, compared to EBSS+Oxygen+Glucose controls. B. Cell death induced by
4 h of OGD becomes apparent between 8 and 24 h post-OGD termination. Analysis of the time course of OGD-induced cell death using Calcein AM
time-lapse assay. Time-lapse imaging of Calcein AM stained cells indicated that OGD-induced cell death became apparent at 8 h and reached
maximum levels at 24 h post-OGD termination. Levels of cell death became significantly higher than controls at 10 h post- OGD termination,
indicated by *, where cell death levels were 18.762.4% and 39.766.4% for control and OGD, respectively (p = 0.045, n = 3). Neuronal cell death levels,
following OGD reach 7562% at 24 h post-OGD termination. Data represent mean 6 SEM.
doi:10.1371/journal.pone.0083717.g001
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caspase 3 and PARP cleavage, classical apoptotic markers. The
PARP Western blot analysis also revealed an absence of 50 kDa
cleavage products that are indicative to necrosis [61] (See also
Figure S1). These data indicate that OGD-induced neuronal cell
death is predominantly apoptotic and therefore mimicks neuronal
cell death in the ischemic penumbra.
Ischemia induces the differential regulation of
microRNAs
Previous studies investigating the role of miRNAs following
ischemic insults have focused on time points where cell death had
already occurred, without differentiation of the miRNA expression
pattern between the apoptotic penumbra and necrotic core, where
the latter infarct area cannot be completely rescued [36–40]. As it
Figure 2. OGD induced cell death demonstrates characteristics of apoptotic cell death. A. The pan-caspase inhibitor, zVAD.fmk at a
concentration of 100 mM, was able to significantly reduce levels of OGD-induced cell death from 70.662%, in naı¨ve cells, to 54.365% in zVAD.fmk
treated cells (p = 0.0459, n = 3) at 24 h post-OGD termination, thus indicating cell death is caspase dependent. B. Western blot analysis shows that
OGD induces cytochrome C release into the cytosolic fraction of cell lysates. OGD also induces activation of Caspase 3, as indicated by the presence of
the cleaved 17 kDa fragment. OGD-treated rat cortical neurons display PARP that has been cleaved to form the classic 89 kDa apoptosis fragment.
The 50 kDa fragment of PARP that is found during necrosis is not detected. C. Quantification of the Western blots demonstrates an increase of
cytochrome C intensity of 0.960.3, in controls, to 2163.7 following OGD (p = 0.0056, n = 3). Quantification of Caspase 3 signal intensity shows a
significant increase in OGD samples reaching 36.665.4 (p = 0.0046, n = 3). Quantification revealed that levels of the 89 kDa PARP fragment changed
from 13.3611 in control cells, to 135.6616 in OGD treated rat cortical neurons (p = 0.0032, n = 3).Data represent Mean 6 SEM.
doi:10.1371/journal.pone.0083717.g002
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is important to establish the differences in cellular response within
these two regions, this study aimed to investigate the regulation of
miRNAs in the potentially salvageable mainly apoptotic ischemic
penumbra. We assessed the miRNA profile of neurons at 8 h post-
OGD termination, before the onset of neuronal cell death
(Figure 1B) and where no nuclear chromatin condensation, a
hallmark of apoptotic cell death, was yet observed (Figure S2). In
addition to this we also analysed the regulation of miRNAs in
RNA extracted from the ipsilateral cortex of mice exposed to 3-
vessel occlusion (3VO) following 24 h of reperfusion, an in vivo
model of stroke [48]. This model represented a more physiological
system where the infarct had already been established (Figure S3).
MiRNA regulation within the necrotic area would presumably
have ceased, since the cells would have died early on and would
have been removed by microglial mediated phagocytosis [80–81];
however, the penumbral area should still be mostly viable at this
time point.
The results of the microarray analysis indicated that a number
miRNAs were differentially regulated following ischemic insults
both in vitro and in vivo (Figure 3). MiRNAs considered for further
study were required to demonstrate an absolute fold change
greater than 1.5 compared to controls, consistently in all biological
and technical repeats. We identified 18 differentially regulated
miRNAs in in vitro samples, of which 5 were significantly down
regulated (miR-664-2*, miR-320, miR-542-3p, miR-381* and
miR-328b-3p) and 6 miRNAs that were significantly up-regulated
(miR-19b, miR-181c, miR-29b-2*, miR-702-5p, miR-410 and
miR-341). The in vivo data suggested that 3VO caused a significant
down-regulation in 17 miRNAs and a significant up-regulation of
41 miRNAs in the ipsilateral (positive for infarct) cortex compared
to the contralateral (Control) cortex.
The comparison of differentially expressed miRNAs in the in
vitro model of the apoptotic penumbra and the in vivo brain
revealed four miRNAs to be dysregulated in both systems: miR-
19b, miR-339-5p, miR-29b-2* and miR-341 (Figure 4A). The
validation of these changes by RT-qPCR (Figure 4B) demonstrat-
ed that miR-19b was up-regulated by 3.861 (p = 0.01, n = 3) and
260.7 (p = 0.02, n = 4)-fold in ischemic samples compared to
control samples in vivo and in vitro, respectively. miR-339-5p was
found to increase its expression by 4.561.7-fold in vivo (p = 0.02,
n = 3) in the ipsilateral cortex when compared to the contralateral
side. This miRNA was up-regulated by 260.3 fold (p = 0.02, n = 4)
in cortical neurons exposed to OGD, compared to control
neurons. Furthermore, miR-29b-2* was confirmed to be increased
in ischemic in vivo and in vitro samples by 360.8 (p = 0.01, n = 3)
and 260.6 (p = 0.02, n = 4)-fold, respectively. Validation of miR-
341 was not performed due to lack of seed sequence conservation
between mice and rats. Taken together, these data confirmed that
miR-19b, miR-339-5p and miR-29b-2* are up-regulated before
neuronal death is detected, in vitro, and following 24 h of
reperfusion, in vivo.
We also generated a model of the apoptotic penumbral neurons
in N2A cell lines, as this model system would allow the modulation
of miRNAs to deduce their mechanism of action in future studies.
The cells were exposed to 4 h of OGD and cell death was
observed significantly higher than controls at 2 h post-OGD
termination, reaching levels of 47.660.8% (p = 0.0006, n = 3)
(Figure S4). We also confirmed by Western blot and electron
microscopy that OGD-induced N2A cell death was apoptotic
(Figure S5).
RT-qPCR analysis of miRNA levels in the N2A cells exposed to
OGD showed that miR-19b, miR-339-5p and miR-29b-2* were
all up-regulated in OGD treated cells in comparison to controls,
by 1.860.1 (p = 0.01, n = 3), 2.260.4 (p = 0.04, n = 3) and
1.460.3 (n = 3)-fold, respectively (Figure 5). Taken together, our
data strongly suggests that these miRNAs are differentially
regulated directly in response to ischemia and not by inherent
factors within each model system. We show that miR-19b, miR-
339-5p and miR-29b-2* are all up-regulated in response to
ischemic insults in 3 model systems: in vivo transient ischemia, in
vitro OGD and N2A OGD. These miRNAs are up-regulated
before neuronal death is detected (in vitro) and when cell death has
been established (in vivo and N2A). These candidates represent
targets for future research to elucidate their mechanism of action,
mRNA targets and role following neuronal ischemia.
Discussion
The present study investigated some aspects of the early
regulatory events associated with the induction of neuronal cell
death in the ischemic penumbra. Since current stroke therapy is
restricted to a narrow therapeutic window, this study focused on
ischemic death in the penumbra that can occur several hours or
weeks after the initial insult, to potentially widen the window for
intervention. Using OGD, we developed an in vitro model of the
apoptotic penumbra in rat cortical neurons. We showed that
OGD was able to induce apoptotic cell death; confirmed by the
detection of characteristic apoptotic hallmarks such as cytochrome
C release, caspase 3 activation and PARP cleavage (Figures 1 and
2). Further, we found that the inhibition of caspases, using the pan-
caspase inhibitor zVAD.fmk, was able to partially reduce levels of
cell death. These results support previous studies that have
identified protection against ischemia-induced cell death following
caspase inhibition in in vivo models [62–64]. The lack of complete
protection against OGD induced death observed in this study is
most likely due to caspase-independent cell death occurring in the
presence of zVAD.fmk [65–71]. Together, our in vitro OGD
treatments represent a model of apoptotic cell death observed in
the ischemic penumbra.
Our study aimed to investigate early regulatory events
associated with ischemia-induced cell death in the salvageable
apoptotic penumbra, with a focus on regulation of gene expression
carried out by miRNAs. The physiological role of miRNAs in the
brain has been well documented [72–76]; furthermore there is
compelling evidence that these non-coding regulatory elements are
implicated in the onset and progression of neurodegenerative
conditions [36,37,38,77,78,79].
Previous studies have provided confirmation for the role of
miRNAs following cerebral ischemia [36–40]. The current study
has focused on the regulation of miRNAs before neuronal cell
death has occurred when miRNA-based regulation would still be
operational. We conducted microarray analysis of miRNAs in the
established OGD model, before neuronal death was detected
(Figure 1B, 3 and S2), thus focusing on an early penumbric event.
In order to detect miRNAs that are differentially regulated in a
more physiologically relevant model, we also assessed miRNAs in
RNA extracted from mice exposed to the 3VO model of cerebral
ischemia, at a time point where cell death had already been
established (Figure 3 and S3) and the cells of the necrotic core are
likely to have been rapidly removed by microglia [80,81], leaving
cells undergoing apoptosis. Together, this allowed the identifica-
tion of miRNAs that are regulated in response to ischemic insult in
the apoptotic penumbra.
Our data shows that 4 miRNAs were up-regulated in response
to ischemia both in vivo and in vitro (Figure 4). We were also able to
validate the changes observed for miR-19b, miR-339-5p and miR-
29b-2*, which have previously been shown to be differentially
regulated following ischemia in animal models and stroke patients
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[36–38]. Importantly, we observe these changes in both mouse
and rat derived model systems (Figure 3 and 4) suggesting an
evolutionarily conserved molecular function. Interestingly, at least
one of these miRNAs, miR-19b, has been identified as up-
regulated in human stroke patients [36]. These data also suggest
that although the three models used in this study involve different
neuronal populations, our identification of common miRNAs
show that similar pathways are being affected by the ischemic
insult. Together, the results imply that these miRNAs could have a
role in the neuronal response to ischemic insults, before apoptotic
cell death occurs in the ischemic infarct. In addition to this, we also
confirmed that these 3 miRNAs are up-regulated in response to
Figure 3. Ischemia induced the differential regulation of miRNAs both in vitro and in vivo. MiRNAs were selected on the basis that their
expression changed by at least 1.5-fold (linear fold change) and are present in all biological repeats (n = 3) and each internal microarray technical
repeat (4), in vitro (A) and in vivo (B). Data represents mean 6 SD. Ns = non-significant. Significance accepted at p,0.05.
doi:10.1371/journal.pone.0083717.g003
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OGD in N2A cells (Figure 5), which confirms that the change is
indeed a response to ischemia rather than a result of other
inherent factors within each model system. Furthermore, confir-
mation of the up-regulation in N2A cells means that these
miRNAs could be modulated in a simple cell line system to deduce
their mechanism of action.
Prediction of miRNA targets can be challenging, as in some
instances mRNA targets are not seed-matched [82]. Using
prediction algorithm software, such as Targetscan (http://www.
targetscan.org/), one can predict some of the mRNA targets of
miRNAs. miR-19b, -339-5p or-29b-2* were not predicted to
directly target any regulators of apoptosis, such as the BCL-2
family, though this does not exclude such a possibility. Neverthe-
less, they could potentially regulate cell death by acting on mRNAs
upstream of the activation of the apoptotic cascade.
The data highlight the importance of identifying the biological
function, targets of these miRNAs and pathways that they impact
to obtain a better understanding of whether they are driving
neuronal cell death following ischemia, or whether they are acting
as a pro-survival signal that eventually fails. These insights will
Figure 4. miR-29b-2*, miR-339-5p and miR-19b are up-regulated in response to in vivo and in vitro ischemia. A. Comparing both in vivo
and in vitro data identified 4 miRNAs common to both models, which are differentially regulated in response to ischemia. B. Taqman Assay q-PCR
confirms the up-regulation of miR-29b-2*, -339-5p and -19b following ischemic insults both in vivo (n = 3) and in vitro (n = 4).
doi:10.1371/journal.pone.0083717.g004
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allow the assessment of their utility as potential therapeutic targets
in efforts to salvage the ischemic penumbra.
Supporting Information
Figure S1 OGD without the addition of APV and (+)MK-
801 induces immediate and caspase-independent cell
death. A. Cell death was analysed immediately after the
termination of OGD (0 h post-OGD Termination) using Sytox/
Hoechst staining. Neurons pre-treated with 10 mM APV and
(+)MK-801 did not show any increase in cell death levels in
comparison to controls. However, without the addition of these
NMDA-receptor antagonists, cell death levels were significantly
increased to 74.461.62% (p,0.001, n = 3). B. 100 mM zVAD.fmk
does not protect against OGD-induced cell death in the absence of
APV and (+)MK-801 when analysed at 24 h post-OGD
termination (n = 3).
(TIF)
Figure S2 OGD-induced condensed chromatin is not
present at 8 h post termination. Hoechst staining of neuronal
nuclei was used to identify condensed chromatin. Neurons exposed
to OGD showed no increase in condensed chromatin, in
comparison to controls, at 8 h post-OGD termination. However,
condensed chromatin was visible at 24 h post-termination.
Representative images of n = 3. Scale bar = 10 mm.
(TIF)
Figure S3 3VO surgery induces neuronal cell death in
the mouse ipsilateral cortex. 2, 3, 5- Triphenyltetrazolium
Chloride (TTC) staining, a metabolic cell indicator of mitochon-
drial activity, was conducted on representative coronal brain
sections from 3-VO operated and sham operated mice. Mouse
brains were sliced into 1 mm thick sections and were stained with
2% TTC in saline, at room temperature for 30 minutes in the
dark. The sections were then fixed in 10% formalin (Sigma) and
stored in the dark at 4uC. The results indicate that cortical lesions
(non-coloured, indicated by arrows) are developed following 3-VO
when assessed following 24 h of reperfusion. Stained areas
represent healthy, non-infarcted tissue.
(TIF)
Figure S4 EBSS induced OGD is toxic to N2A cells. A.
N2As were exposed to a 4 h OGD insult using EBSS. Cell death
was analysed at 0, 2 and 4 h post-OGD termination by examining
Annexin V and PI incorporation using flow cytometry. The data
indicates that total levels of cell death become significant at 2 h
post-OGD termination (47.6360.79%), in comparison to the 0 h
time point (21.8562.47%) (p = 0.0006, n = 3). These cell death
levels are maintained when analysed at 4 h post-OGD termination
(50.5563.14%, n = 3). In comparison, control cells are unaffected
by equivalent treatments, in the presence of oxygen and glucose.
(n = 3). Data represent mean 6 SEM.
(TIF)
Figure S5 OGD in N2As induces cell death that displays
characteristic hallmarks of apoptosis. A. N2As exposed to
4 h of OGD were examined for PARP cleavage and generation of
the cleaved active caspase 3 fragment by Western analysis. The
representative blots illustrate that OGD has induced a substantial
increase in the cleaved PARP product of 89 kDa, characteristic of
apoptosis, in comparison to the 0 h time point. Furthermore, this
cleavage product is still present when examined at 4 h post OGD
termination. Western analysis for the 17 kDa active cleavage
product of caspase 3 also showed a large increase in its abundance
at 2 h post-OGD termination, in comparison with the 0 h sample.
The 17 kDA cleavage product declined in levels by 4 h post-OGD
termination, when compared to the 2 h sample. The diagram
represents a representative image from n = 3. B. N2As exposed to
OGD show morphological characteristics of apoptosis. Electron
microscopy was utilised to identify morphological hallmarks of
apoptosis at 2 and 4 h post-OGD termination. Control images
depict representative images of healthy cells. A small number of
cells appear to be lysed (open arrow), illustrating basal death levels
in the culture. At 2 h post-OGD termination cells with budding
membranes (closed arrow) and condensed chromatin (dashed
arrow) can be detected. Budding membranes and condensed
chromatin are also detected at 4 h post OGD termination. (n = 1)
Scale bar = 5 mm.
(TIF)
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